triple-hormone-receptor agonist retatrutide for obesity - a phase 2 trial ⭐️topline results from TRIUMPH-1, 3 clinical evaluating #retatrutide, an investigational GIP / GLP-1 / glucagon triple hormone receptor agonist, in adults with or “overweight” Mazdutide vs retatrutide: dual agonist

Analytical testing typically includes high-performance liquid chromatography (HPLC) to confirm purity levels and mass spectrometry (MS) to verify molecular weight and structural identity

However, no evidence of clinical implications of TMAO in the central nervous system has been documented as yet, but TMAO is present at detectable levels in the cerebro-spinal fluid (CSF)

10.1038/s41582-018-0047-2 21 BannwarthS.Ait-El-MkademS.ChaussenotA.GeninE

GHK-Cu (systemic) Already covered in healing section, but worth noting for skin: Improves skin quality throughout body Hair growth and thickness Anti-aging effects Better results than topical for some people Melanotan I (Afamelanotide) Primary uses: Tanning without sun exposure Protection against UV damage Erythropoietic protoporphyria treatment Typical dosing: 0.5-1mg daily until desired tan achieved Then 0.5-1mg 2-3x weekly for maintenance Administration: Subcutaneous injection Special notes: Safer than Melanotan II (no libido/nausea effects) FDA-approved for EPP (rare condition) Causes gradual tanning Permanent skin darkening with continued use Specialty and niche peptides Less common but valuable for specific purposes